Guidance on the cardiovascular safety of Cox-2 inhibitors and NSAIDs and further reading.
Medicines and Healthcare products Regulatory Agency guidance for healthcare professionals on the cardiovascular safety of Cox-2 inhibitors and NSAIDs including safety reviews carried out.
2 January 2015
Medicines and Healthcare products Regulatory Agency
Medicines and medical devices: product-specific information
Don’t include personal or financial information like your National Insurance number or credit card details.